Group purchasing organization Novation awarded new cardiovascular contracts to a host of market leaders, effective at the beginning of 2013.
Among the companies awarded were Abbott (NYSE:ABT), C.R. Bard (NYSE:BCR), Biotronik, Boston Scientific (NYSE:BSX), Cook Medical, Covidien (NYSE:COV), Medtronic (NYSE:MDT) and St. Jude Medical (NYSE:STJ).
Novation signed deals for cardiovascular products including cardiac rhythm management, electrophysiology, coronary, peripheral vascular, neuro interventional and vascular closure.
"Because cardiovascular procedures are such a vital part of their daily health care delivery, members will spend more than $3.5 billion in 2013 on cardiovascular products with these awarded suppliers," Novation VP of physician preference & sourcing operations Michael Vintges said in prepared remarks. "Our cardiovascular portfolio delivers choice and value through the breadth of products offered with the various market leaders."
The GPO provided a table to illustrate the individual categories awarded to each supplier:
The agreements were negotiated through member-driven public competitive bid process, the GPO said.
Novation earlier this month awarded a contract to Cook Medical for devices including biopsy needles, balloons, balloon stents and launched a new reusable packaging initiative for U.S. hospitals to go green with reusable packaging in healthcare.